Only qualified healthcare providers may order

Pharmacogenetics Panel (PGx Panel)

Pharmacogenomic testing provides information about many different genes and how they impact the body’s response to over one hundred drugs. For example, DNA variants can show that a patient needs a higher or lower dose of a certain drug or that a different drug should be used instead. Pharmacogenomics is one piece of information that can be used by physicians to make better medication decisions for their patient.

This test(s) was developed, and performance characteristics were determined by the HudsonAlpha Clinical Services Lab, LLC. The U.S. Food and Drug Administration (FDA) has not approved or cleared this test; however, FDA clearance or approval is not currently required for clinical use. These tests are used for clinical purposes, and therefore validation was done as required under the requirements of the Clinical Laboratory Improvement Act (CLIA) of 1988. The results are not intended to be used as the sole means for clinical diagnosis or patient management decisions. The chance of a false negative or a false-positive result due to laboratory error cannot be completely excluded. These results should not be regarded as investigational or for research.